Zobrazeno 1 - 10 of 102 pro vyhledávání: '"Romanenko Vv"'
1
Akademický článek
Post-Vaccination and Post-Infection Immunity to the Hepatitis B Virus and Circulation of Immune-Escape Variants in the Russian Federation 20 Years after the Start of Mass Vaccination.
Autor: Asadi Mobarkhan FA; Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Manuylov VA; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Karlsen AA; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.; Scientific and Educational Resource Center for High-Performance Methods of Genomic Analysis, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia., Kichatova VS; Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Potemkin IA; Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Lopatukhina MA; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Isaeva OV; Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Mullin EV; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Mazunina EP; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Bykonia EN; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Kleymenov DA; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Popova LI; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Gushchin VA; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Tkachuk AP; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Saryglar AA; Hospital of Infectious Diseases, 667003 Kyzyl, Russia., Kravchenko IE; Department of Infectious Diseases, Kazan State Medical University of the Ministry of Healthcare of Russia, 420012 Kazan, Russia., Sleptsova SS; Medical Institute, M.K. Ammosov North-Eastern Federal University, 677010 Yakutsk, Russia., Romanenko VV; Medical Faculty, Ural State Medical University, 620014 Yekaterinburg, Russia., Kuznetsova AV; Center for the Prevention and Control of AIDS and Infectious Diseases under Health Ministry of Khabarovsk Region, 680031 Khabarovsk, Russia., Solonin SA; N.V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department, 129090 Moscow, Russia., Semenenko TA; Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Mikhailov MI; Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.; Medical Faculty, Belgorod State National Research University, 308015 Belgorod, Russia., Kyuregyan KK; Department of Socially Significant Viral Infections, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.; Scientific and Educational Resource Center for High-Performance Methods of Genomic Analysis, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia.
Publikováno v: Vaccines [Vaccines (Basel)] 2023 Feb 13; Vol. 11 (2). Date of Electronic Publication: 2023 Feb 13.
Zobrazit plný text záznamu
3
Safety and Immunogenicity of Two Doses of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Indian and Russian Children Aged 9 to 17 Months
Autor: Bakul B Javadekar, Olga Perminova, Yaël Thollot, Alexander Goldstein, Apurba Ghosh, Shally Awasthi, Susanna Kharit, Vera Rodnikova, Valérie Bosch-Castells, Romanenko Vv, Himanshu Dubey, Rajeev Zachariah Kompithra
Publikováno v: Indian pediatrics. 55(12)
Evaluation of tolerability, safety and immunogenicity of a two-dose series of a quadrivalent meningococcal polysaccharide diptheria toxoid conjugate (ACYW-D) vaccine in Indian and Russian infants/toddlers. Open-label, single-arm, phase III multi-nati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a4dc185e8477bbbea854ea1e29fee9a
https://pubmed.ncbi.nlm.nih.gov/30745476
Zobrazit plný text záznamu
4
Akademický článek
Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage.
Autor: Kyuregyan KK; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.; Scientific and Educational Resource Center for High-Performance Methods of Genomic Analysis, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia., Lopatukhina MA; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Asadi Mobarkhan FA; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Kichatova VS; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Potemkin IA; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Isaeva OV; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Karlsen AA; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.; Scientific and Educational Resource Center for High-Performance Methods of Genomic Analysis, Peoples' Friendship University of Russia (RUDN University), 117198 Moscow, Russia., Malinnikova EY; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Kaira AN; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia., Kozhanova TV; Department of Neurology, Neurosurgery and Medical Genetics, Faculty of Pediatrics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.; Chumakov Federal Scientific Center for Research, Development of Immunobiological Products, Russian Academy of Sciences, 108819 Moscow, Russia., Manuylov VA; Translational Biomedicine Laboratory, Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Mazunina EP; Translational Biomedicine Laboratory, Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Bykonia EN; Translational Biomedicine Laboratory, Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Kleymenov DA; Translational Biomedicine Laboratory, Gamaleya National Research Center for Epidemiology and Microbiology, 123098 Moscow, Russia., Ignateva ME; The Sakha Republic (Yakutia) Regional Department of Rospotrebnadzor, 677027 Yakutsk, Russia., Trotsenko OE; Khabarovsk Research Institute of Epidemiology and Microbiology, 680000 Khabarovsk, Russia., Kuznetsova AV; Center for the Prevention and Control of AIDS and Infectious Diseases, Health Ministry of Khabarovsk Region, 680031 Khabarovsk, Russia., Saryglar AA; Hospital of Infectious Diseases, 667003 Kyzyl, Russia., Oorzhak ND; Tuva Regional Department of Rospotrebnadzor, 667010 Kyzyl, Russia., Romanenko VV; Medical Faculty, Ural State Medical University, 620014 Yekaterinburg, Russia., Mikhailov MI; Department of Viral Hepatitis, Russian Medical Academy of Continuous Professional Education, 125993 Moscow, Russia.; Laboratory of Viral Hepatitis, Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.; Medical Faculty, Belgorod State National Research University, 308015 Belgorod, Russia.
Publikováno v: Vaccines [Vaccines (Basel)] 2022 Aug 29; Vol. 10 (9). Date of Electronic Publication: 2022 Aug 29.
Zobrazit plný text záznamu
6
Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
Autor: R S Fassakhov, Francisco Abad-Santos, Lars Rombo, Mamadou Dramé, Jan Hendrik Richardus, Romanenko Vv, José-María Bayas, José-Ramón de Juanes, H.C. Rumke, Tino F Schwarz, Frank von Sonnenburg, W. Ripley Ballou, Xavier Duval, Magda Campins, Covadonga Caso, Roland Sänger
Publikováno v: Vaccine. 26:2378-2388
A multicentre, randomized, phase III clinical trial in 5071 healthy adults was conducted to evaluate the safety and reactogenicity of a 15 microg HA dose of a candidate oil-in-water emulsion-based adjuvant system (AS)-adjuvanted split-virion H5N1 (AS
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140b14c2afb3efe56720a21f70162929
https://doi.org/10.1016/j.vaccine.2008.02.068
Zobrazit plný text záznamu
7
Akademický článek
Development of measures for limiting negative impacts of the «Atomic» lake on population and environment.
Autor: Subbotin SB; Department of Development of Environment Monitoring Systems, 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Aidarkhanov AO; 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Romanenko VV; Department of Development of Environment Monitoring Systems, 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Krivitskiy PY; Department of Radioecological Research and Environment Remediation, 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Umarov MA; 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Monaenko VN; Education and Information Center, 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Lyakhova ON; Department of Development of Environment Monitoring Systems, 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Shatrov AN; Department of Analytical Research, 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan., Suprunov VI; Department of Development of Environment Monitoring Systems, 'Institute of Radiation Safety and Ecology' (IRSE) of 'National Nuclear Center of the Republic of Kazakhstan', Kazakhstan. Electronic address: visuprunov@yandex.kz., Kitamura А; Japan Atomic Energy Agency, Japan.
Publikováno v: Journal of environmental radioactivity [J Environ Radioact] 2020 Nov; Vol. 223-224, pp. 106389. Date of Electronic Publication: 2020 Sep 18.
Zobrazit plný text záznamu
8
Akademický článek
Comparison of the Immunogenicity and Safety of Two Pediatric TBE Vaccines Based on the Far Eastern and European Virus Subtypes.
Autor: Vorovitch MF; Federal State Budgetary Scientific Institution 'Chumakov Federal Scientific Center for Research and Development of Immune-and-biological Products of Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia.; Sechenov First Moscow State Medical University, 119991 Moscow, Russia., Maikova GB; Federal State Budgetary Scientific Institution 'Chumakov Federal Scientific Center for Research and Development of Immune-and-biological Products of Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Chernokhaeva LL; Federal State Budgetary Scientific Institution 'Chumakov Federal Scientific Center for Research and Development of Immune-and-biological Products of Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia., Romanenko VV; Federal Budgetary Healthcare Institution 'Center for Hygiene and Epidemiology in the Sverdlovsk Region', 620078 Yekaterinburg, Russia., Karganova GG; Federal State Budgetary Scientific Institution 'Chumakov Federal Scientific Center for Research and Development of Immune-and-biological Products of Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia.; Sechenov First Moscow State Medical University, 119991 Moscow, Russia., Ishmukhametov AA; Federal State Budgetary Scientific Institution 'Chumakov Federal Scientific Center for Research and Development of Immune-and-biological Products of Russian Academy of Sciences' (FSBSI 'Chumakov FSC R&D IBP RAS'), 108819 Moscow, Russia.; Sechenov First Moscow State Medical University, 119991 Moscow, Russia.
Publikováno v: Advances in virology [Adv Virol] 2019 Dec 24; Vol. 2019, pp. 5323428. Date of Electronic Publication: 2019 Dec 24 (Print Publication: 2019).
Zobrazit plný text záznamu
9
Origin and Distribution of Tick-Borne Encephalitis Virus Strains of the Siberian Subtype in the Middle Urals, the North-West of Russia and the Baltic Countries
Autor: D. N. Chernykh, Kokorev Vs, T. E. Snitkovskaya, S. Yu. Kovalev, Romanenko Vv
Publikováno v: J. Gen. Virol.
Journal of General Virology
Tick-borne encephalitis virus (TBEV) plays an important role in infectious human morbidity, particularly in Russia and the Middle Urals. The Siberian subtype of TBEV (S-TBEV) is dominant in the Middle Urals. Determining the origin of S-TBEV strains i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d847a00341d6a6d00486e22fb4627e18
https://hdl.handle.net/10995/111958
Zobrazit plný text záznamu
10
Akademický článek
Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
Autor: Maikova GB; Chumakov Institute of Poliomyelitis and Viral Encephalitides, FSBSI 'Chumakov FSC IBP RAS,', Moscow, Russia., Chernokhaeva LL; Chumakov Institute of Poliomyelitis and Viral Encephalitides, FSBSI 'Chumakov FSC IBP RAS,', Moscow, Russia., Rogova YV; Chumakov Institute of Poliomyelitis and Viral Encephalitides, FSBSI 'Chumakov FSC IBP RAS,', Moscow, Russia., Kozlovskaya LI; Chumakov Institute of Poliomyelitis and Viral Encephalitides, FSBSI 'Chumakov FSC IBP RAS,', Moscow, Russia.; Institute for Translational Medecine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia., Kholodilov IS; Chumakov Institute of Poliomyelitis and Viral Encephalitides, FSBSI 'Chumakov FSC IBP RAS,', Moscow, Russia., Romanenko VV; Hygienic and Epidemiological Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing in Sverdlovsk Region, Ekaterinburg, Russia., Esyunina MS; Office of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing in Sverdlovsk Region, Ekaterinburg, Russia., Ankudinova AA; Ekaterinburg Scientific Research Institute of Virus Infections, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Ekaterinburg, Russia., Kilyachina AS; Ekaterinburg Scientific Research Institute of Virus Infections, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Ekaterinburg, Russia., Vorovitch MF; Chumakov Institute of Poliomyelitis and Viral Encephalitides, FSBSI 'Chumakov FSC IBP RAS,', Moscow, Russia.; Institute for Translational Medecine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia., Karganova GG; Chumakov Institute of Poliomyelitis and Viral Encephalitides, FSBSI 'Chumakov FSC IBP RAS,', Moscow, Russia.; Institute for Translational Medecine and Biotechnology, Sechenov First Moscow State Medical University, Moscow, Russia.
Publikováno v: Journal of medical virology [J Med Virol] 2019 Feb; Vol. 91 (2), pp. 190-200. Date of Electronic Publication: 2018 Oct 28.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje